These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 36810167)

  • 1. Efficacy of clozapine compared with other second-generation antipsychotic drugs in patients with treatment-resistant schizophrenia: protocol for a systematic review and individual patient data meta-analysis of randomised controlled trials.
    Siafis S; Schneider-Thoma J; Hamza T; Bighelli I; Dong S; Hansen WP; Davis JM; Salanti G; Leucht S
    BMJ Open; 2023 Feb; 13(2):e064504. PubMed ID: 36810167
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy, Acceptability, and Tolerability of Antipsychotics in Treatment-Resistant Schizophrenia: A Network Meta-analysis.
    Samara MT; Dold M; Gianatsi M; Nikolakopoulou A; Helfer B; Salanti G; Leucht S
    JAMA Psychiatry; 2016 Mar; 73(3):199-210. PubMed ID: 26842482
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clozapine combined with different antipsychotic drugs for treatment resistant schizophrenia.
    Cipriani A; Boso M; Barbui C
    Cochrane Database Syst Rev; 2009 Jul; (3):CD006324. PubMed ID: 19588385
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clozapine versus typical neuroleptic medication for schizophrenia.
    Wahlbeck K; Cheine M; Essali MA
    Cochrane Database Syst Rev; 2000; (2):CD000059. PubMed ID: 10796289
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolic side effects of antipsychotic drugs in individuals with schizophrenia during medium- to long-term treatment: protocol for a systematic review and network meta-analysis of randomized controlled trials.
    Schneider-Thoma J; Kapfhammer A; Wang D; Bighelli I; Siafis S; Wu H; Hansen WP; Davis JM; Salanti G; Leucht S
    Syst Rev; 2021 Aug; 10(1):214. PubMed ID: 34340713
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative efficacy and tolerability of 15 antipsychotic drugs in schizophrenia: a multiple-treatments meta-analysis.
    Leucht S; Cipriani A; Spineli L; Mavridis D; Orey D; Richter F; Samara M; Barbui C; Engel RR; Geddes JR; Kissling W; Stapf MP; Lässig B; Salanti G; Davis JM
    Lancet; 2013 Sep; 382(9896):951-62. PubMed ID: 23810019
    [TBL] [Abstract][Full Text] [Related]  

  • 8. EstablishINg the best STEp-up treatments for children with uncontrolled asthma despite INhaled corticosteroids (EINSTEIN): protocol for a systematic review, network meta-analysis and cost-effectiveness analysis using individual participant data (IPD).
    Cividini S; Sinha I; Donegan S; Maden M; Culeddu G; Rose K; Fulton O; Hughes DA; Turner S; Tudur Smith C
    BMJ Open; 2021 Feb; 11(2):e040528. PubMed ID: 33550231
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Non-invasive brain stimulation for treatment-resistant schizophrenia: protocol of a systematic review and network meta-analysis.
    Siafis S; Lorenz C; Wu H; Zhu Y; Schneider-Thoma J; Bighelli I; Li C; Hansen WP; Padberg F; Salanti G; Leucht S
    Syst Rev; 2024 Jun; 13(1):165. PubMed ID: 38915121
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An open, large, 6-month naturalistic study of outcome in schizophrenic outpatients, treated with olanzapine.
    Krzystanek M; Krupka-Matuszczyk I
    Hum Psychopharmacol; 2011 Jan; 26(1):81-5. PubMed ID: 23055416
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The response of subgroups of patients with schizophrenia to different antipsychotic drugs: a systematic review and meta-analysis.
    Leucht S; Chaimani A; Krause M; Schneider-Thoma J; Wang D; Dong S; Samara M; Peter N; Huhn M; Priller J; Davis JM
    Lancet Psychiatry; 2022 Nov; 9(11):884-893. PubMed ID: 36228647
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-acting injectable versus oral antipsychotics for the maintenance treatment of schizophrenia: a systematic review and comparative meta-analysis of randomised, cohort, and pre-post studies.
    Kishimoto T; Hagi K; Kurokawa S; Kane JM; Correll CU
    Lancet Psychiatry; 2021 May; 8(5):387-404. PubMed ID: 33862018
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Newer atypical antipsychotic medication versus clozapine for schizophrenia.
    Tuunainen A; Wahlbeck K; Gilbody SM
    Cochrane Database Syst Rev; 2000; (2):CD000966. PubMed ID: 10796559
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antipsychotic treatment for children and adolescents with schizophrenia spectrum disorders: protocol for a network meta-analysis of randomised trials.
    Pagsberg AK; Tarp S; Glintborg D; Stenstrøm AD; Fink-Jensen A; Correll CU; Christensen R
    BMJ Open; 2014 Oct; 4(10):e005708. PubMed ID: 25304189
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clozapine and Psychosocial Function in Schizophrenia: A Systematic Review and Meta-Analysis.
    Olagunju AT; Clark SR; Baune BT
    CNS Drugs; 2018 Nov; 32(11):1011-1023. PubMed ID: 30155842
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antipsychotic drugs and their effects on cognitive function: protocol for a systematic review, pairwise, and network meta-analysis.
    Feber L; Peter N; Schneider-Thoma J; Siafis S; Bighelli I; Hansen WP; Prates Baldez D; Salanti G; Keefe RSE; Engel RR; Leucht S
    Syst Rev; 2023 Mar; 12(1):54. PubMed ID: 36959619
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sequential Multiple-Assignment Randomized Trials to Compare Antipsychotic Treatments (SMART-CAT) in first-episode schizophrenia patients: Rationale and trial design.
    Li X; Guo X; Fan X; Feng T; Wang C; Yao Z; Xu X; Chen Z; Wang H; Xie S; He J; Zhuo K; Xiang Q; Cen H; Wang J; Smith RC; Jin H; Keshavan MS; Marder SR; Davis JM; Jiang K; Xu Y; Liu D
    Schizophr Res; 2021 Apr; 230():87-94. PubMed ID: 33279374
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effectiveness of second-generation antipsychotics in patients with treatment-resistant schizophrenia: a review and meta-analysis of randomized trials.
    Chakos M; Lieberman J; Hoffman E; Bradford D; Sheitman B
    Am J Psychiatry; 2001 Apr; 158(4):518-26. PubMed ID: 11282684
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Antipsychotics in bipolar disorders].
    Vacheron-Trystram MN; Braitman A; Cheref S; Auffray L
    Encephale; 2004; 30(5):417-24. PubMed ID: 15627046
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modafinil for people with schizophrenia or related disorders.
    Ortiz-Orendain J; Covarrubias-Castillo SA; Vazquez-Alvarez AO; Castiello-de Obeso S; Arias Quiñones GE; Seegers M; Colunga-Lozano LE
    Cochrane Database Syst Rev; 2019 Dec; 12(12):CD008661. PubMed ID: 31828767
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.